Jaguar Health, Inc. (JAGX) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Jaguar Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.162 -- 00:00:05.869 Good morning. Before I turn the call over to management, I'd like to remind you that 00:00:05.869 -- 00:00:11.057 management may make forward-looking statements relating to such matters as continued 00:00:11.057 -- 00:00:16.725 growth prospects for the company, uncertainties regarding market acceptance of products, 00:00:16.725 -- 00:00:22.473 the impact of competitive products and pricing, industry trends, and product initiatives, 00:00:22.473 -- 00:00:27.781 including products in development stage which may not achieve scientific 00:00:27.781 -- 00:00:30.473 objectives or meet stringent regulatory standards. 00:00:30.473 -- 00:00:32.473 requirements. 00:00:33.457 -- 00:00:38.144 Forward-looking statements are subject to risks and uncertainties that could cause actual 00:00:38.144 -- 00:00:42.971 results to differ materially from those contemplated in such forward-looking statements. 00:00:42.971 -- 00:00:48.178 These statements are made based on current available information and management's current 00:00:48.178 -- 00:00:52.364 assumptions, expectations, and projections about future events. 00:00:52.364 -- 00:00:57.011 While management believes its assumptions, expectations, and projections are reasonable 00:00:57.011 -- 00:01:02.092 in view of the currently available information, you are cautioned not to place undue 00:01:02.092 -- 00:01:07.259 reliance on forward-looking statements. The company's actual results may differ materially 00:01:07.259 -- 00:01:12.586 from those discussed during this webcast for a variety of reasons, including those described 00:01:12.586 -- 00:01:17.774 in the forward-looking statements and risk factor sections of the company's Form 10-K 00:01:17.774 -- 00:01:22.941 for the year 2024, which was filed...